Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer
dc.contributor.author | Walsh, C | en_US |
dc.contributor.author | Bonner, JJ | en_US |
dc.contributor.author | Johnson, TN | en_US |
dc.contributor.author | Neuhoff, S | en_US |
dc.contributor.author | Ghazaly, EA | en_US |
dc.contributor.author | Gribben, JG | en_US |
dc.contributor.author | Boddy, AV | en_US |
dc.contributor.author | Veal, GJ | en_US |
dc.date.accessioned | 2017-01-12T10:42:34Z | |
dc.date.available | 2015-12-29 | en_US |
dc.date.issued | 2016-05 | en_US |
dc.date.submitted | 2016-08-16T16:40:49.399Z | |
dc.identifier.issn | 0306-5251 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/18499 | |
dc.format.extent | 989 - 998 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | en_US |
dc.rights | CC-BY | |
dc.subject | actinomycin D | en_US |
dc.subject | cancer | en_US |
dc.subject | paediatrics | en_US |
dc.subject | pharmacokinetics | en_US |
dc.subject | physiologically based pharmacokinetic modelling | en_US |
dc.title | Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer | en_US |
dc.type | Article | |
dc.rights.holder | © 2016 The Authors. | |
dc.identifier.doi | 10.1111/bcp.12878 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000375109100018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 5 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 81 | en_US |
Files in this item
This item appears in the following Collection(s)
-
Centre for Cancer Prevention [1147]